The store will not work correctly when cookies are disabled.
(E)-2-((1H-pyrrolo[2,3-b]pyridin-3-yl)methylene)-5-methoxy-2,3-dihydro-1H-inden-1-one
ID: ALA4640071
PubChem CID: 156015760
Max Phase: Preclinical
Molecular Formula: C18H14N2O2
Molecular Weight: 290.32
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc2c(c1)C/C(=C\c1c[nH]c3ncccc13)C2=O
Standard InChI: InChI=1S/C18H14N2O2/c1-22-14-4-5-15-11(9-14)7-12(17(15)21)8-13-10-20-18-16(13)3-2-6-19-18/h2-6,8-10H,7H2,1H3,(H,19,20)/b12-8+
Standard InChI Key: OTYRCIPBLBUKKI-XYOKQWHBSA-N
Molfile:
RDKit 2D
22 25 0 0 0 0 0 0 0 0999 V2000
18.8930 -4.7091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8919 -5.5287 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5999 -5.9376 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.5981 -4.3003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3068 -4.7055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3070 -5.5287 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0900 -5.7829 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.5737 -5.1167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0896 -4.4510 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3419 -3.6737 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1411 -3.5035 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7491 -4.0452 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4737 -2.7520 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.2865 -2.8370 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4562 -3.6343 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.2301 -3.8845 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8350 -3.3384 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.6607 -2.5388 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8871 -2.2924 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0642 -2.0448 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.6130 -3.5884 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.2185 -3.0396 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 15 1 0
14 13 1 0
13 11 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
13 20 2 0
17 21 1 0
21 22 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 290.32 | Molecular Weight (Monoisotopic): 290.1055 | AlogP: 3.39 | #Rotatable Bonds: 2 |
Polar Surface Area: 54.98 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 3.28 | CX LogP: 2.98 | CX LogD: 2.98 |
Aromatic Rings: 3 | Heavy Atoms: 22 | QED Weighted: 0.74 | Np Likeness Score: -0.48 |
References
1. Qhobosheane MA, Legoabe LJ, Josselin B, Bach S, Ruchaud S, Petzer JP, Beteck RM.. (2020) Synthesis and evaluation of 7-azaindole derivatives bearing benzocycloalkanone motifs as protein kinase inhibitors., 28 (11): [PMID:32284225] [10.1016/j.bmc.2020.115468] |